Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Carcinogenesis of Gα12 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using Ga12 Inhibitor.

NCT01919580 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01919580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01919580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Carcinogenesis of Gα12 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using Ga12 Inhibitor.
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2012
Completion date
July 31, 2014
Enrollment
255 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinogenesis, oral cancer